We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Affirms Injunction, Wait Period To Market Biosimilar Drug

(July 8, 2016, 12:29 PM EDT) -- WASHINGTON, D.C. — A Florida federal judge properly awarded Amgen Inc. a preliminary injunction barring Apotex Inc. from entering the market for 180 days after receiving a requested license from the...
To view the full article, register now.